1. Home
  2. ACHV vs RIBB Comparison

ACHV vs RIBB Comparison

Compare ACHV & RIBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • RIBB
  • Stock Information
  • Founded
  • ACHV N/A
  • RIBB 2024
  • Country
  • ACHV United States
  • RIBB Japan
  • Employees
  • ACHV N/A
  • RIBB N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • RIBB
  • Sector
  • ACHV Health Care
  • RIBB
  • Exchange
  • ACHV Nasdaq
  • RIBB NYSE
  • Market Cap
  • ACHV 72.5M
  • RIBB 64.9M
  • IPO Year
  • ACHV N/A
  • RIBB 2025
  • Fundamental
  • Price
  • ACHV $2.26
  • RIBB $10.15
  • Analyst Decision
  • ACHV Strong Buy
  • RIBB
  • Analyst Count
  • ACHV 3
  • RIBB 0
  • Target Price
  • ACHV $14.33
  • RIBB N/A
  • AVG Volume (30 Days)
  • ACHV 1.2M
  • RIBB 7.5K
  • Earning Date
  • ACHV 08-12-2025
  • RIBB 01-01-0001
  • Dividend Yield
  • ACHV N/A
  • RIBB N/A
  • EPS Growth
  • ACHV N/A
  • RIBB N/A
  • EPS
  • ACHV N/A
  • RIBB N/A
  • Revenue
  • ACHV N/A
  • RIBB N/A
  • Revenue This Year
  • ACHV N/A
  • RIBB N/A
  • Revenue Next Year
  • ACHV N/A
  • RIBB N/A
  • P/E Ratio
  • ACHV N/A
  • RIBB N/A
  • Revenue Growth
  • ACHV N/A
  • RIBB N/A
  • 52 Week Low
  • ACHV $1.84
  • RIBB $9.95
  • 52 Week High
  • ACHV $5.31
  • RIBB $10.45
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 35.12
  • RIBB N/A
  • Support Level
  • ACHV $2.00
  • RIBB N/A
  • Resistance Level
  • ACHV $3.90
  • RIBB N/A
  • Average True Range (ATR)
  • ACHV 0.28
  • RIBB 0.00
  • MACD
  • ACHV -0.18
  • RIBB 0.00
  • Stochastic Oscillator
  • ACHV 13.68
  • RIBB 0.00

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About RIBB RIBBON ACQUISITION CORP

Ribbon Acquisition Corp is a blank check company.

Share on Social Networks: